This report describes a survey of people accessing homeless services or staying in encampments who may have been previously infected with undetected mpox.
This report describes interim clinical treatments for severe mpox developed following the evaluation of treatment data, cases, input from clinicians, and more.
This report describes 54% effectiveness for the 2023-23 influenza vaccine for preventing medically attended influenza A infection in people older than 65 years.
This report describes up to 4 months of protection against COVID-19 among children aged 3–5 and 3–4 year who received monovalent primary series vaccinations.
This report describes higher protection against COVID-19 infection and death among people who received an updated booster than people who received a monovalent booster.
This report describes how the median completed COVID-19 vaccinations series among older adults in 2022 was 76%, which is below the WHO goal, especially in middle- and low-income countries.
This report describes how continued monitoring of S-gene target failure and S-gene target presence patterns will likely serve as a useful complement to genomic surveillance of SARS-CoV-2 lineages.
This report describes how a bivalent mRNA booster dose provided additional protection against symptomatic XBB/XBB.1.5 infection for at least the first 3 months after vaccination in persons who had previously received 2–4 monovalent vaccine doses.
This report describes higher rates of pediatric hospitalization and symptomatic illness from influenza among children during the 2022–23 season in Tennessee.
This report describes an investigation of mental and physical health symptoms reported among residents a year after a chemical exposure fire in Winnebago County, Illinois.
This report describes similar early safety findings from the Vaccine Adverse Event Reporting System for bivalent booster vaccination in children aged 5–11 years as the monovalent booster vaccination.
This report describes 2021 data from National Center for Health Interview Survey on the percentage of adults who have ever had hepatitis by age group and sex.
This report describes declines in vaccination coverage reported by the National Immunization Survey–Child among young children born during 2018–2019 living below the federal poverty level and in rural areas.
This report describes overall low COVID-19 vaccination coverage among children and adolescents 5–17 years old and parental intent to vaccinate their child.
This report describes cases of mpox among cisgender women and the use of tecovirimat with no reported adverse reaction to treat four pregnant people with mpox.